Publications by authors named "Alessandro Careggio"
Page 1 of 1
Synopsis of recent research by authors named "Alessandro Careggio"
- Alessandro Careggio's recent research focuses on evaluating the safety and efficacy of antiplatelet therapies, specifically comparing ticagrelor and clopidogrel in elderly patients following acute coronary syndrome (ACS) and assessing the outcomes of P2Y12 inhibitors monotherapy after dual antiplatelet therapy.
- In his 2021 study involving over 16,000 patients treated with percutaneous coronary intervention (PCI), Careggio found that ticagrelor may be associated with a higher risk of major bleeding compared to clopidogrel, raising concerns about its use in older populations.
- Another significant contribution is a meta-analysis of randomized controlled trials that included nearly 29,000 patients, which suggests that early interruption of aspirin after PCI may be considered to improve safety without sacrificing antithrombotic efficacy, aligning with the ongoing development of new antiplatelet therapies.
